Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.

AUTOR(ES)

Rodenhuis, S

RESUMO

OBJECTIVE--Major thromboses can occur in the venous system in association with central venous catheters. This usually necessitates removal of the catheter. METHODS--The effectiveness of low dose recombinant tissue type plasminogen activator (rt-PA) in combination with heparin was assessed in patients with central venous catheter associated thrombosis. RESULTS--In five patients, all suffering from cancer, a 5-7 day continuous infusion resulted in complete lysis of the thrombus without complications in three. In the other two patients moderately severe haemorrhage was observed with only partial lysis, of the thrombus. CONCLUSIONS--The infusion of heparin and rt-PA is potentially effective in thrombosis related to use of central venous catheters, but the risk of haemorrhage is not inconsiderable.

Documentos Relacionados

• Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.
• Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator.
• A simple quantitative assay of tissue plasminogen activator.
• Origins of the specificity of tissue-type plasminogen activator.
• Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator.